
A Further Stride in the IMMray PanCan-d Verification Study
Immunovia announces positive results from the verification study, the last stride towards the launch of IMMray PanCan-d.
FREMONT, CA: Immunovia, a diagnostic company that provides highly accurate blood tests for the early identification of cancer and autoimmune diseases, announces positive results from the verification study and will now commence the validation study, the last stride towards the release of IMMray PanCan-d. The verification study analysis exhibits results in line with the previous commercial test model study (CTMS), which opens the way for the final blinded validation study.
The company is highly pleased with the verification study results and is now commencing the preparation for the validation process while finishing up some bioinformatics for all subgroups of samples. These results will be made public as fast as the study is completed in all its details. The company remains fully committed to the release of IMMray PanCan-d and are now only one step away from the Q4 start sales of IMMray PanCan-d.
The study was conducted to verify the IMMray PanCan-d commercial biomarker signature using samples and to further validate its accuracy in differentiating PDAC (pancreatic ductal adenocarcinoma) stages I via IV vs. controls that best mirror the clinical, commercial setting situation that is patients with non-specific but concerning symptoms. All the samples were freshly gathered through its Key Opinion Leaders (KOL) at pancreatic illnesses reference sites in the USA and Europe. The verification study precedes the last blinded validation test required for sales start.
Immunovia AB is a diagnostic firm producing and commercializing highly accurate blood tests for the early identification of cancer and autoimmune diseases based on Immunovia’s proprietary test platform called IMMray. Tests are based on antibody biomarker microarray analysis using advanced machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a unique disease biomarker signature.
Featured Vendors
Tenthpin: The Trusted Advisor for Data-Driven Patient- Centric Value Chain Management in Life Sciences
Process Stream: Into the Depths: How Process Stream Leverages Experience and Embedded Research to Transform Businesses from the Inside Out
Indegene: Leveraging Technology to Drive Growth and Productivity Investing In Innovation In Operations, Analytics and Clinical Technology
MMIS: Global Compliance Platform Streamlines Processes and Delivers Business Intelligence Enterprise-Wide
Acceliant: Leading with Innovation, Facilitating Collaboration, Standardization and Productivity in Clinical Trial Management
Saama Technologies: New Fluid Analytics Engine from Saama Cost-Effectively and Rapidly Resolves Complex Data Analytics Challenges for Life Sciences
Iris Interactive Corporation: Boosting Collaboration and Decision Making Processes to Bring Products
Techsol Corporation: Offering Domain Rich, Regulatory Compliant, Accelerated and Cloud Enabled Techn
Solea Software Solutions: Offering Business Intelligence, Analytics, and Portal Services for Flouris
Xybion Corporation: Providing Interconnected Technology Enabled Solutions for Life Sciences, and oth
EDITOR'S PICK
Essential Technology Elements Necessary To Enable...
By Leni Kaufman, VP & CIO, Newport News Shipbuilding
Comparative Data Among Physician Peers
By George Evans, CIO, Singing River Health System
Monitoring Technologies Without Human Intervention
By John Kamin, EVP and CIO, Old National Bancorp
Unlocking the Value of Connected Cars
By Elliot Garbus, VP-IoT Solutions Group & GM-Automotive...
Digital Innovation Giving Rise to New Capabilities
By Gregory Morrison, SVP & CIO, Cox Enterprises
Staying Connected to Organizational Priorities is Vital...
By Alberto Ruocco, CIO, American Electric Power
Comprehensible Distribution of Training and Information...
By Sam Lamonica, CIO & VP Information Systems, Rosendin...
The Current Focus is On Comprehensive Solutions
By Sergey Cherkasov, CIO, PhosAgro
Big Data Analytics and Its Impact on the Supply Chain
By Pascal Becotte, MD-Global Supply Chain Practice for the...
Technology's Impact on Field Services
By Stephen Caulfield, Executive Director, Global Field...
Carmax, the Automobile Business with IT at the Core
By Shamim Mohammad, SVP & CIO, CarMax
The CIO's role in rethinking the scope of EPM for...
By Ronald Seymore, Managing Director, Enterprise Performance...
Driving Insurance Agent Productivity with Mobile and Big...
By Brad Bodell, SVP and CIO, CNO Financial Group, Inc.
Transformative Impact On The IT Landscape
By Jim Whitehurst, CEO, Red Hat
Get Ready for an IT Renaissance: Brought to You by Big...
By Clark Golestani, EVP and CIO, Merck
Four Initiatives Driving ECM Innovation
By Scott Craig, Vice President of Product Marketing, Lexmark...
Technology to Leverage and Enable
By Dave Kipe, SVP, Global Operations, Scholastic Inc.
By Meerah Rajavel, CIO, Forcepoint
AI is the New UI-AI + UX + DesignOps
By Amit Bahree, Executive, Global Technology and Innovation,...
Evolving Role of the CIO - Enabling Business Execution...
By Greg Tacchetti, CIO, State Auto Insurance
Read Also
